Search details
1.
Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance.
Hum Genomics
; 12(1): 51, 2018 11 20.
Article
in English
| MEDLINE | ID: mdl-30458859
2.
Diagnostic mRNA splicing assay for variants in BRCA1 and BRCA2 identified two novel pathogenic splicing aberrations.
Hered Cancer Clin Pract
; 17: 14, 2019.
Article
in English
| MEDLINE | ID: mdl-31143303
3.
BRCA1 and BRCA2 mutation spectrum - an update on mutation distribution in a large cancer genetics clinic in Norway.
Hered Cancer Clin Pract
; 16: 3, 2018.
Article
in English
| MEDLINE | ID: mdl-29339979
4.
Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers.
BMC Cancer
; 17(1): 438, 2017 Jun 21.
Article
in English
| MEDLINE | ID: mdl-28637432
5.
Functional Analyses of Rare Germline Missense BRCA1 Variants Located within and outside Protein Domains with Known Functions.
Genes (Basel)
; 14(2)2023 01 19.
Article
in English
| MEDLINE | ID: mdl-36833189
6.
BRCA1 Norway: comparison of classification for BRCA1 germline variants detected in families with suspected hereditary breast and ovarian cancer between different laboratories.
Fam Cancer
; 21(4): 389-398, 2022 10.
Article
in English
| MEDLINE | ID: mdl-34981296
7.
BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer.
ESMO Open
; 3(3): e000328, 2018.
Article
in English
| MEDLINE | ID: mdl-29682331
Results
1 -
7
de 7
1
Next >
>>